Men with erectile dysfunction (ED) are the main patients for the combo drug Sildalist 120 mg. The two active components in it are tadalafil and sildenafil citrate. As a phosphodiesterase type 5 (PDE5) inhibitor, sildenafil, also marketed as Viagra, helps to relax the blood vessels in the penis, enhancing blood flow during sexual stimulation. Aurogra 100 is ED treatments with sildenafil citrate, enhancing blood flow for erections. Compared to sildenafil, tadalafil, also marketed as Cialis, is a PDE5 inhibitor with a longer half-life. By combining these two medications, Sildalist 120 mg seeks to treat ED more thoroughly and to produce both short-term and long-term results.

The effectiveness of Sildalist 120 mg is dependent on the patient's health and how the drug interacts with it. When used as directed, it is usually well tolerated, though it might not be appropriate for everyone. When using this medicine, anyone with liver or kidney impairment, cardiovascular problems, or those taking medications that interact with PDE5 inhibitors should use it carefully and under medical supervision.